{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "Gsk.com"}, "author": null, "title": "enters agreement to acquire Aiolos Bio | GSK - GSK", "description": "Acquisition expands GSK\u2019s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody.", "url": "https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-aiolos-bio/", "urlToImage": "https://www.gsk.com/assets/img/GSK_Logo_Full_Colour_RGB.png?mode=pad&width=350&height=157", "publishedAt": "2024-01-09T07:06:44Z", "content": "<ul><li>Acquisition expands GSKs respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway</li><li>AIO-001 could redefine the standar\u2026 [+5813 chars]"}, {"source": {"id": null, "name": "Theregister.com"}, "author": "Thomas Claburn", "title": "OpenAI: 'Impossible to train today\u2019s leading AI models without using copyrighted materials' - The Register", "description": "As IEEE study shows super lab's neural nets can emit 'plagiaristic output'", "url": "https://www.theregister.com/2024/01/08/midjourney_openai_copyright/", "urlToImage": "https://regmedia.co.uk/2024/01/08/shutterstock_openai.jpg", "publishedAt": "2024-01-08T21:59:00Z", "content": "OpenAI has said it would be \"impossible\" to build top-tier neural networks that meet today's needs without using people's copyrighted work. The Microsoft-backed lab, which believes it is lawfully har\u2026 [+9107 chars]"}]}